File #: 220816    Version: 1 Name: Committee of the Whole - Closed Session - Settlement of Lawsuit - Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Par Pharmaceutical, Inc. and Par Pharmaceutical Companies, Inc. - City to Receive $10,000,000 - July 19, 2022, at 3:00 p.m.
Type: Motion Status: Passed
Introduced: 7/12/2022 In control: Clerk of the Board
On agenda: Final action: 7/19/2022
Enactment date: 7/19/2022 Enactment #: M22-124
Title: Motion scheduling the Board of Supervisors to sit as a Committee of the Whole at the meeting on July 19, 2022, at 3:00 p.m. to hold a public hearing to consider the proposed ordinance (File No. 220819) endorsing partial settlement of the lawsuit filed on behalf of the City and County of San Francisco and the People of the State of California against manufacturers and distributors of prescription opioids, entitled The City and County of San Francisco and the People of the State of California v. Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A. Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics, Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc F/K/A Actavis Plc, Watson Pharmaceuticals, Inc. N/K/A Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. F/K/A/ Watson Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation; and scheduling a closed session of the Board of Supervisors at the same meeting for the purpose of conferring with, or receiving advice from, the City Attorney regarding that existing litigation in which the City is a plaintiff, pursuant to California Government Code, Section 54956.9(a), and San Francisco Administrative Code, Section 67.10(d)(1).
Sponsors: Shamann Walton
Attachments: 1. Leg Ver1, 2. Board Pkt 071922, 3. Leg Final
Related files: 220817, 220818, 220819
Date Ver.Action ByActionResultAction DetailsMeeting DetailsVideo
7/19/20221 Board of Supervisors APPROVEDPass Action details Meeting details Not available
7/12/20221 President REFERRED FOR ADOPTION WITHOUT COMMITTEE REFERENCE AGENDA AT THE NEXT BOARD MEETING  Action details Meeting details Not available
Legislation Details
 *NOTE: These reports are produced in HTML format and are accessible to screen readers.